Calcium carbonate
Highest phase reached
Approved
Drug type
Small molecule
First approval year
2000
- First approval year
- 2000
- Listing at source
- Listed
- Highest phase reached
- Approved
- Drug type
- Small molecule
- Drug name
- Calcium carbonate
- Molecular weight
- 100.09
- Structure (SMILES)
- O=C([O-])[O-].[Ca+2]
- adcal
- Adcal
- albacar
- Albacar
- cacit
- Cacit
- calc 500
- Calc 500
- calcette
- Calcette
- calcichew
- Calcichew
- calcichew fte
- Calcichew fte
- calcidrink
- Calcidrink
- calcium carbonate component of pepcid complete
- Calcium carbonate component of pepcid complete
- citrical
- Citrical
- os cal
- Os-cal
- purecal
- Purecal
- remegel
And 13 more, listed on the interactive page.
- amlodipine freeze dried powder for oral solution 5 mg
- Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
- calcii carbonas
- Calcii carbonas
- CALCII CARBONAS [WHO-IP LATIN]
- calcii carbonas who ip latin
- calcite
- Calcite
- Calcite (ca(co3))
- calcite ca co3
- calcitum
- Calcitum
- Calcium (as calcium carbonate)
- CALCIUM (AS CALCIUM CARBONATE) [VANDF]
- Calcium (as carbonate)
- CALCIUM (AS CARBONATE) [VANDF]
- calcium as calcium carbonate
- calcium as calcium carbonate vandf
- calcium as carbonate
- calcium as carbonate vandf
- calcium carbonate
- Calcium carbonate
- CALCIUM CARBONATE [EP MONOGRAPH]
- CALCIUM CARBONATE [FCC]
- CALCIUM CARBONATE [HSDB]
And 66 more, listed on the interactive page.
- CAS registry numbers
- 471-34-1
- ChEMBL ID
- CHEMBL1200539
- InChIKey
- VTYYLEPIZMXCLO-UHFFFAOYSA-L
- RxNorm IDs (RxCUI)
- 1897
- FDA ingredient codes (UNII)
- H0G9379FGK
- A02AC01
- A12AA04
Sources for recorded values
- 10112
- 516889
- Applicant
- KENVUE BRANDS
- Approval date
- 16 Oct 2000
- Application number
- NDA020958
- Patents
- 0
- Designations
- 1
- First in class
- No
- Fast track
- No
- Breakthrough designation
- No
- Orphan designation
- No
- Priority review
- No
- Orphan exclusivity
- No
- Accelerated approval
- No
- Availability
- Over the counter
Administration routes
- Oral
- Condition
- HIV Infections
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000180
- Subject identifier
- D015658
- Condition
- Atrial Fibrillation
- Highest recorded phase
- 0.5
- Condition identifier
- EFO:0000275
- Subject identifier
- D001281
- Condition
- Diabetic Nephropathies
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000401
- Subject identifier
- D003928
- Condition
- Lymphoma
- Highest recorded phase
- 3
- Condition identifier
- EFO:0000574
- Subject identifier
- D008223
- Condition
- HIV Infections
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000764
- Subject identifier
- D015658
- Condition
- Obesity
- Highest recorded phase
- 2
- Condition identifier
- EFO:0001073
- Subject identifier
- D009765
- Condition
- Liver Cirrhosis
- Highest recorded phase
- 3
- Condition identifier
- EFO:0001422
- Subject identifier
- D008103
- Condition
- Arthritis, Juvenile
- Highest recorded phase
- 2
- Condition identifier
- EFO:0002609
- Subject identifier
- D001171
- Condition
- Pregnancy
- Highest recorded phase
- 1
- Condition identifier
- EFO:0002950
- Subject identifier
- D011247
- Condition
- Vitamin D Deficiency
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003762
- Subject identifier
- D014808
- Condition
- Dental Caries
- Highest recorded phase
- 0.5
- Condition identifier
- EFO:0003819
- Subject identifier
- D003731
- Condition
- Osteoporosis, Postmenopausal
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003854
- Subject identifier
- D015663
- Condition
- Breast Neoplasms
- Highest recorded phase
- 2
- Condition identifier
- EFO:0003869
- Subject identifier
- D001943
- Condition
- Osteoporosis
- Highest recorded phase
- 4
- Condition identifier
- EFO:0003882
- Subject identifier
- D010024
- Condition
- Renal Insufficiency, Chronic
- Highest recorded phase
- 2
- Condition identifier
- EFO:0003884
- Subject identifier
- D051436
- Condition
- Gastroesophageal Reflux
- Highest recorded phase
- 1
- Condition identifier
- EFO:0003948
- Subject identifier
- D005764
- Condition
- Radius Fractures
- Highest recorded phase
- 1
- Condition identifier
- EFO:0003957
- Subject identifier
- D011885
- Condition
- Anemia
- Highest recorded phase
- 4
- Condition identifier
- EFO:0004272
- Subject identifier
- D000740
- Condition
- Colonic Neoplasms
- Highest recorded phase
- 1
- Condition identifier
- EFO:0004288
- Subject identifier
- D003110
- Condition
- Lymphoma, Non-Hodgkin
- Highest recorded phase
- 3
- Condition identifier
- EFO:0005952
- Subject identifier
- D008228
- Condition
- Hypoparathyroidism
- Highest recorded phase
- 1
- Condition identifier
- EFO:0009451
- Subject identifier
- D007011
- Condition
- Aging
- Highest recorded phase
- 2
- Condition identifier
- EFO:0022597
- Subject identifier
- D000375
- Condition
- Chronic Kidney Disease-Mineral and Bone Disorder
- Highest recorded phase
- 2
- Condition identifier
- EFO:1001152
- Subject identifier
- D012080
- Condition
- Hyperparathyroidism, Secondary
- Highest recorded phase
- 2
- Condition identifier
- EFO:1001173
- Subject identifier
- D006962
- Condition
- Bone Diseases, Metabolic
- Highest recorded phase
- 3
- Condition identifier
- HP:0000938
- Subject identifier
- D001851
And 6 more, listed on the interactive page.
- Condition identifier
- EFO_0000401
- Highest recorded phase
- 2
- Condition identifier
- EFO_0000764
- Highest recorded phase
- 2
- Condition identifier
- EFO_0001422
- Highest recorded phase
- 3
- Condition identifier
- EFO_0002609
- Highest recorded phase
- 2
- Condition identifier
- EFO_0003762
- Highest recorded phase
- 3
- Condition identifier
- EFO_0003841
- Condition identifier
- EFO_0003854
- Highest recorded phase
- 3
- Condition identifier
- EFO_0003882
- Condition identifier
- EFO_0003884
- Highest recorded phase
- 2
- Condition identifier
- EFO_0003948
- Highest recorded phase
- 1
- Condition identifier
- EFO_0004272
- Condition identifier
- EFO_0004272
- Highest recorded phase
- 4
- Condition identifier
- EFO_0004288
- Highest recorded phase
- 1
- Condition identifier
- EFO_0009451
- Highest recorded phase
- 2
- Condition identifier
- EFO_0009909
- Condition identifier
- EFO_1001152
- Highest recorded phase
- 2
- Condition identifier
- EFO_1001173
- Highest recorded phase
- 2
- Condition identifier
- HP_0001324
- Highest recorded phase
- 1
- Condition identifier
- HP_0002014
- Highest recorded phase
- 3
- Condition identifier
- HP_0002901
- Condition identifier
- HP_0002901
- Highest recorded phase
- 4
- Condition identifier
- HP_0004349
- Highest recorded phase
- 2
- Condition identifier
- HP_0025502
- Highest recorded phase
- 3
- Condition identifier
- MONDO_0000328
- Condition identifier
- MONDO_0000328
- Highest recorded phase
- 3
And 17 more, listed on the interactive page.
- Event
- abdominal discomfort
- Reports
- 2,535
- Reporting signal score
- 7,265.69
- Event
- alopecia
- Reports
- 2,566
- Reporting signal score
- 7,353.31
- Event
- anti-cyclic citrullinated peptide antibody positive
- Reports
- 990
- Reporting signal score
- 4,848.62
- Event
- arthralgia
- Reports
- 970
- Reporting signal score
- 837.602
- Event
- arthropathy
- Reports
- 1,486
- Reporting signal score
- 4,443.3
- Event
- asthma
- Reports
- 205
- Reporting signal score
- 155.737
- Event
- blister
- Reports
- 466
- Reporting signal score
- 906.169
- Event
- blood cholesterol increased
- Reports
- 222
- Reporting signal score
- 338.107
- Event
- c-reactive protein abnormal
- Reports
- 70
- Reporting signal score
- 141.364
- Event
- calciphylaxis
- Reports
- 75
- Reporting signal score
- 220.129
- Event
- coma
- Reports
- 179
- Reporting signal score
- 170.414
- Event
- condition aggravated
- Reports
- 1,161
- Reporting signal score
- 1,405.04
- Event
- confusional state
- Reports
- 451
- Reporting signal score
- 372.676
- Event
- contusion
- Reports
- 335
- Reporting signal score
- 406.844
- Event
- disability
- Reports
- 72
- Reporting signal score
- 138.602
- Event
- discomfort
- Reports
- 1,273
- Reporting signal score
- 4,084.56
- Event
- drug intolerance
- Reports
- 1,420
- Reporting signal score
- 3,103.73
- Event
- duodenal ulcer perforation
- Reports
- 615
- Reporting signal score
- 2,829.64
- Event
- dyspnoea
- Reports
- 686
- Reporting signal score
- 200.689
- Event
- fatigue
- Reports
- 2,384
- Reporting signal score
- 2,752.13
- Event
- fibromyalgia
- Reports
- 118
- Reporting signal score
- 192.53
- Event
- folliculitis
- Reports
- 330
- Reporting signal score
- 1,101.33
- Event
- gastrointestinal disorder
- Reports
- 355
- Reporting signal score
- 496.896
- Event
- gastrooesophageal reflux disease
- Reports
- 233
- Reporting signal score
- 248.948
- Event
- general physical health deterioration
- Reports
- 408
- Reporting signal score
- 520.344
And 56 more, listed on the interactive page.
- NCT00000429
- NCT00043069
- NCT00054418
- NCT00112437
- NCT00421343
- NCT00960934
- NCT00996801
- NCT01120600
- NCT00061256
- NCT01762995
- NCT02473367
- NCT00073073
- NCT00263185
- NCT00352846
- NCT00486512
- NCT00529373
- NCT00620113
- NCT01552122
- NCT00560300
- NCT00650637
- NCT00967629
- NCT01493050
- NCT01052051
- NCT03057314
- NCT01190683
And 20 more, listed on the interactive page.
- Dose
- 2-4 tablets
- Route
- Oral
- How often
- As needed
- Prodrug
- No
- Chirality
- Achiral
- Inorganic
- No
- Heavy atoms
- 5
- Molecular formula
- CCaO3
- Monoisotopic mass
- 99.9473347
- Natural product
- No
- 13925-116
- 13925-117
- 39328-106
- 42192-320
- 42192-332
- 50967-219
- 59088-005
- 59088-008
- 59088-009
- 59088-078
- 59088-139
- 59088-156
- 59088-164
- 59088-165
- 59088-166
- 59088-167
- 59088-168
- 59088-169
- 59088-171
- 59088-172
- 59088-173
- 59088-176
- 59088-177
- 59088-178
- 59088-180
And 21 more, listed on the interactive page.
- Recorded assays
- 16
- Active assays
- 0
- Antacids
Related records
Trials (146)
- A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)
- A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)
- A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried
- A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years
- A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years
- A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy
- A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants
- A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh
- A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors
- A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powder Injection in Chinese Healthy Subjects
- A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine
- A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency
- A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects
- A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults
- A Study on the Prevention and Treatment of GIOP With Eldecalcitol
- A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets (0208C-145)(COMPLETED)
- A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis
- A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121
- A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea
- A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried
Approved for (3)
- Anemia
- Dyspepsia
- Osteoporosis
In development for (25)
- Alcohol dependence Phase 3
- Atrial fibrillation Early phase 1
- Breast neoplasm Phase 2
- Cancer Phase 2
- Chronic kidney disease Phase 2
- Cirrhosis of liver Phase 3
- Classic familial adenomatous polyposis Phase 3
- Colonic neoplasm Phase 1
- Dental caries Early phase 1
- Diabetic kidney disease Phase 2
- Diarrheal disease Phase 3
- Gastroesophageal reflux disease Phase 1
- HIV infectious disease Phase 2
- Hyperphosphatemia Phase 3
- Hypoparathyroidism Phase 1
- Juvenile idiopathic arthritis Phase 2
- Lymphoma Phase 3
- Metabolic bone disorder Phase 3
- Non-Hodgkin lymphoma Phase 3
- Obesity disorder Phase 2
Other linked conditions (2)
- Acute kidney injury
- Thyroid tumor